Another Major Drug Approval for Regeneron
Congratulations to BCW member Regeneron on the approval of an important new drug to help patients with rheumatoid arthritis. The U.S. Food and Drug Administration has approved the human antibody drug sarilumab, developed by Regeneron Pharmaceuticals Inc. in Westchester and its French pharmaceutical partner Sanofi and trademarked as Kevzara, to treat adult patients with moderately to severely active rheumatoid arthritis.
The FDA approval came less than two months after the federal agency approved Regeneron’s and Sanofi’s human antibody dupilumab, marketed as Dupixent, as the first biologic medicine used to treat the debilitating itching and widespread rashes afflicting adults with moderate to severe cases of atopic dermatitis.
Similar News Items
What does it take to lead with purpose, grace, and energy — for decades — without burning out? In this inspiring conversation, BCW Member and Balancing Life’s Issues CEO/President Wendy Wollner sits down with Dr. Marsha Gordon, President and CEO of The Business Council of Westchester. A trailblazing leader who transformed a struggling local chamber […]
A new collaboration between the Business Council of Westchester (BCW) and Iona University is deploying the innovative power of design thinking to address two community challenges in the Town of Greenburgh. Iona business students will lead the latest City Labs project—a key component of the BCW’s Westchester Innovation Network (WIN). The students will focus on […]
In what was the Business Event of the Year in Westchester County, The Business Council of Westchester (BCW) held its Annual Dinner on October 27 at the VIP Country Club in New Rochelle, celebrating the region’s healthcare excellence with the theme, “Honoring the Legacy of Healthcare in the Hudson Valley.” More than 500 attendees were […]
Become A Member
Join the county’s largest and most influential business organization today.
JOIN NOW!
Leave a Comment
You must be logged in to post a comment.